Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuel Mignot

Showing results (201-210 of 356) with videos related to

Pageof 36
Sort By:
Medrxiv : the Preprint Server for Health Sciences|February 19, 2024
Stability and Volatility of Human Rest-Activity Rhythms: Insights from Very Long Actograms (VLAs)Nandani Adhyapak, Mark A Abboud, Pallavi S K Rao, et al.
Sleep|March 8, 2023
Safety and pharmacodynamics of a single infusion of danavorexton in adults with idiopathic hypersomniaEmmanuel Mignot, Richard K Bogan, Helene Emsellem, et al.
Sleep Medicine|November 1, 2003
The narcoleptic borderland: a multimodal diagnostic approach including cerebrospinal fluid levels of hypocretin-1 (orexin A)Claudio Bassetti, Matthias Gugger, Matthias Bischof, et al.
Sleep|July 2, 2021
Arousal characteristics in patients with Parkinson's disease and isolated rapid eye movement sleep behavior disorderAndreas Brink-Kjær, Matteo Cesari, Friederike Sixel-Döring, et al.
Sleep Medicine|November 28, 2015
The diagnostic value of power spectra analysis of the sleep electroencephalography in narcoleptic patientsJulie Anja Engelhard Christensen, Emil Gammelmark Schreiner Munk, Paul E Peppard, et al.
Annals of Neurology|April 29, 2008
Kleine-Levin syndrome: a systematic study of 108 patientsIsabelle Arnulf, Ling Lin, Nathan Gadoth, et al.
Neurology|June 23, 2012
Early IVIg treatment has no effect on post-H1N1 narcolepsy phenotype or hypocretin deficiencyStine Knudsen, Bo Biering-Sørensen, Birgitte R Kornum, et al.
The Lancet. Neurology|January 22, 2022
Safety and efficacy of daridorexant in patients with insomnia disorder: results from two multicentre, randomised, double-blind, placebo-controlled, phase 3 trialsEmmanuel Mignot, David Mayleben, Ingo Fietze, et al.
Sleep|November 26, 2009
Body mass index-independent metabolic alterations in narcolepsy with cataplexyFrancesca Poli, Giuseppe Plazzi, Guido Di Dalmazi, et al.
Sleep|September 30, 2004
The diurnal rhythm of hypocretin in young and old F344 ratsFrank Desarnaud, Eric Murillo-Rodriguez, Ling Lin, et al.
Pageof 36

Showing results (201-210 of 356) with videos related to

Sort By:
Pageof 36
Medrxiv : the Preprint Server for Health Sciences|February 19, 2024
Stability and Volatility of Human Rest-Activity Rhythms: Insights from Very Long Actograms (VLAs)Nandani Adhyapak, Mark A Abboud, Pallavi S K Rao, et al.
Sleep|March 8, 2023
Safety and pharmacodynamics of a single infusion of danavorexton in adults with idiopathic hypersomniaEmmanuel Mignot, Richard K Bogan, Helene Emsellem, et al.
Sleep Medicine|November 1, 2003
The narcoleptic borderland: a multimodal diagnostic approach including cerebrospinal fluid levels of hypocretin-1 (orexin A)Claudio Bassetti, Matthias Gugger, Matthias Bischof, et al.
Sleep|July 2, 2021
Arousal characteristics in patients with Parkinson's disease and isolated rapid eye movement sleep behavior disorderAndreas Brink-Kjær, Matteo Cesari, Friederike Sixel-Döring, et al.
Sleep Medicine|November 28, 2015
The diagnostic value of power spectra analysis of the sleep electroencephalography in narcoleptic patientsJulie Anja Engelhard Christensen, Emil Gammelmark Schreiner Munk, Paul E Peppard, et al.
Annals of Neurology|April 29, 2008
Kleine-Levin syndrome: a systematic study of 108 patientsIsabelle Arnulf, Ling Lin, Nathan Gadoth, et al.
Neurology|June 23, 2012
Early IVIg treatment has no effect on post-H1N1 narcolepsy phenotype or hypocretin deficiencyStine Knudsen, Bo Biering-Sørensen, Birgitte R Kornum, et al.
The Lancet. Neurology|January 22, 2022
Safety and efficacy of daridorexant in patients with insomnia disorder: results from two multicentre, randomised, double-blind, placebo-controlled, phase 3 trialsEmmanuel Mignot, David Mayleben, Ingo Fietze, et al.
Sleep|November 26, 2009
Body mass index-independent metabolic alterations in narcolepsy with cataplexyFrancesca Poli, Giuseppe Plazzi, Guido Di Dalmazi, et al.
Sleep|September 30, 2004
The diurnal rhythm of hypocretin in young and old F344 ratsFrank Desarnaud, Eric Murillo-Rodriguez, Ling Lin, et al.
Pageof 36